MUMBAI, 20 February 2024: Rallis India Ltd., a leading player in the agri-inputs industry, has announced the successful commercialization of three new products in its Custom Synthesis & Manufacturing (CSM) portfolio during FY24.
These additions span across the agrochemical value chain, encompassing intermediates, active ingredients (AI), and formulations. Notably, two of these products are manufactured at Rallis India's new manufacturing plants in Dahej.
This expansion has led to a broader CSM customer base, particularly among Japanese innovator agrochemical companies.
Key Highlights
Rallis India commercializes 3 new CSM products in FY24.
Products span intermediates, AI, and formulations.
Two new products manufactured at Dahej plants.
Expansion strengthens presence among Japanese agrochemical companies.
Speaking on this development, Sanjiv Lal, MD & CEO: "This CSM portfolio expansion reflects our commitment to chemistry-led manufacturing, supported by our Dahej investments. These successes solidify the trust we hold from global agrochemical companies."
S. Nagarajan, COO: "The commercialization showcases our enhanced capabilities in handling complex chemistries and sustainable formulations. We deliver high-quality products at competitive prices while upholding strict EHS standards."
Looking Ahead
Rallis India remains dedicated to further expanding and scaling up its product portfolio. The company aims to strengthen existing partnerships and build new ones with global agrochemical companies to advance sustainable agriculture.
Keywords: Rallis India, CSM, agrochemicals, custom synthesis, manufacturing, Dahej, Japan, sustainable agriculture, intermediates, active ingredients, formulations.
